Harvard Business Review

SEPTEMBER 23, 2014

Take the case of Janssen, the pharmaceuticals arm of Johnson & Johnson, which created a breakthrough innovative program called Immersion. Creating a spirit of internal cooperation and cohesion has been crucial. There are plenty of pundits arguing that big companies need to innovate, and pointing out that it is difficult to do so.

Innovation 11

Innovation P&L Short-term Company 11

Harvard Business Review

SEPTEMBER 15, 2014

As Linda Hill and her colleagues have described, the company needed expert knowledge as it navigated the technically and ethically challenging waters of pharmaceutical development and marketing. But the specialist law firms that it employed rarely cooperated with one another or even shared much information.

Gilbert 9

Gilbert Participative Cooper Network Economy 9

Harvard Business Review

OCTOBER 13, 2011

The pharmaceutical industry also creates products with complex interactions and potentially dangerous side effects. Banks can simulate the pharmaceutical approach, and learn much about consumer behavior and its evolution — without putting customers at risk. Here, the protocols from other industries can provide some insight.

Banking 10

Banking Pharmaceuticals Microfinance Risk Management 10

Harvard Business Review

DECEMBER 14, 2015

Chirag Patel, CEO of Amneal Pharmaceuticals and Ernst & Young 2011 Entrepreneur of the Year, credits meditation with helping him feel more connected to his clients. Peter Cooper, founder of Cooper Investors, attributes his ability to invest wisely to his meditation practice.

CEO 8

CEO Emotional Intelligence Cooper Pharmaceuticals 8

Harvard Business Review

OCTOBER 29, 2012

If the cost of innovation is falling, that should enable more of it from poorer countries, companies or cooperatives. Some of this may just be the product of the high regulatory costs in pharmaceuticals, but research by Harvard's F.M. If it's not, the already big and already rich will dominate innovation.

Cost 8

Cost Innovation Wireless Disruptive Innovation 8

Harvard Business Review

MARCH 24, 2017

Despite having solid internal anti-corruption rules in place, the pharmaceutical giant wound up facing criminal investigations for bribing doctors and foreign officials , eventually paying a $489 million fine. If there is a disconnect, that is a red flag. Consider the case of GSK. The company sought claims against those employees.

Ethics 8

Ethics Company Incentives Policies 8

Harvard Business Review

SEPTEMBER 14, 2011

We recently visited the brand-new R&D lab of Dr Reddy's , one of India's leading pharmaceutical firms. Cultural differences can severely hamper cooperation between Western and Eastern engineers. This lab isn't located in Bangalore or Hyderabad (where Dr Reddy's is headquartered) but in. Cambridge, U.K. and the U.K.

Globalization 9

Globalization Innovation Decentralization Chemicals 9

Harvard Business Review

SEPTEMBER 7, 2015

From cooperation to competition, a game with multiplayer features taps into the rich culture of board games humans have been playing for centuries. How would a pharmaceutical company react, for example, when a new innovation disrupts the industry’s cost structure?

Seminar 8

Seminar Learning Curve Strategy Comparison 8

Harvard Business Review

MARCH 27, 2018

Unlike some pharmaceuticals, data-opolies do not charge consumers exorbitant prices. When there are only a few firms, this can increase the likelihood of companies secretly cooperating with the government to provide access to data. Ordinarily the harm from monopolies are higher prices, less output, or reduced quality.

Company 11

Company Advertising Incentives Engineering 11

Strategy Driven

JANUARY 24, 2011

Plus, as a result of a lack of cross-organizational coordination and cooperation, Nokia wasn’t able to improve its proprietary operating system, Symbian, which would have allowed it to support a more sophisticated smartphone. The BRIDGE that failed for Gap Makers #2, 3, and 4 : Company-Wide Coordination and Cooperation.

Execution 67

Execution Company 360-Degree Feedback Cooper 67

Harvard Business Review

OCTOBER 27, 2015

At UCB, a medium-sized pharmaceutical company headquartered in Belgium, Heresh Rezavandi and his managers Michelle Maddix-Sovero are leading a young strategic intelligence function that’s part of the strategic marketing practice. There are, of course, exceptions — and other companies can learn from them.

Marketing 8

Marketing Competitive Intelligence Porter How To 8

Harvard Business Review

NOVEMBER 28, 2016

Today, the clinical and genetic information of cancer patients is held in a variety of places: academic medical centers, community hospitals, disease-specific foundations, pharmaceutical companies, and the government. Efforts like these are likely to improve the ways the members of the precision medicine ecosystem cooperate.

Pharmaceuticals 8

Pharmaceuticals Information Health Care Cooper 8